Cañás M - Search Results

1

A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy.

da Silva Machado FL, Cañás M, Urtasun MA, Marín GH, Albuquerque FC, Pont L, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Lopes LC. da Silva Machado FL, et al. Among authors: canas m. Ther Innov Regul Sci. 2024 May;58(3):549-556. doi: 10.1007/s43441-024-00623-8. Epub 2024 Mar 4. Ther Innov Regul Sci. 2024. PMID: 38436905

2

Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.

Machado FLDS, Cañás M, Doubova SV, Urtasun MA, Marín GH, Osorio-de-Castro CGS, Albuquerque FC, Ribeiro TB, Pont L, Crisóstomo Landeros J, Roldán Saelzer J, Sepúlveda Viveros D, Acosta A, Machado Beltrán MA, Gordillo Alas LI, Orellana Tablas LA, Benko R, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Contreras Sánchez SE, Rodríguez-Tanta LY, Gutierrez Aures Y, Lin B, Alipour-Haris G, Eworuke E, Lopes LC. Machado FLDS, et al. Among authors: canas m. Regul Toxicol Pharmacol. 2023 Oct;144:105485. doi: 10.1016/j.yrtph.2023.105485. Epub 2023 Sep 1. Regul Toxicol Pharmacol. 2023. PMID: 37659711

3

Therapeutic value and price of the new pharmaceuticals commercialized in Argentina: Are they worth what they cost?

Cañás M, Buschiazzo HO, Urtasun MA. Cañás M, et al. Salud Colect. 2019 Mar 10;15:e1962. doi: 10.18294/sc.2019.1962. Salud Colect. 2019. PMID: 31141093 English, Spanish.

4

Data transparency for building a stronger healthcare system: A case study from Argentinean administrative drug utilization data sources.

Cañás M, Marín GH, Urtasun MA, Leal LF, Salas M, Elseviers M, Lopes LC. Cañás M, et al. Salud Colect. 2021 May 27;17:e3339. doi: 10.18294/sc.2021.3339. Salud Colect. 2021. PMID: 34105332 English.

5

[Economic impact of high-price/cost medicines on social security in Argentina. The case of the Institute for the Armed and Security Forces].

Marin GH, Cañas M, Marin G, Marin L, Nucher D, Diaz Pérez D, Urtasun M. Marin GH, et al. Among authors: canas m. Medicina (B Aires). 2023;83(1):65-73. Medicina (B Aires). 2023. PMID: 36774599 Free article. Spanish.

6

[Salt in the diet: opinions, guides and evidence].

Urtasun MA, Cañás M. Urtasun MA, et al. Among authors: canas m. Salud Colect. 2017 Jan-Mar;13(1):149-152. doi: 10.18294/sc.2017.1320. Salud Colect. 2017. PMID: 28562732 Free article. Spanish. No abstract available.

7

[Concordance between essential medicines lists and diabetes guidelines in Latin America and the CaribbeanConcordância entre as listas de medicamentos essenciais e diretrizes para diabetes na América Latina e no Caribe].

Urtasun MA, Dorati C, Cañás M, Bruzzone MS, Marín GH, Iusef Venturini N, Mordujovich Buschiazzo P. Urtasun MA, et al. Among authors: canas m. Rev Panam Salud Publica. 2024 Feb 12;48:e3. doi: 10.26633/RPSP.2024.3. eCollection 2024. Rev Panam Salud Publica. 2024. PMID: 38352034 Free PMC article. Spanish.

8

Potential negative impact of reputed regulators' decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis.

Durán CE, Cañás M, Urtasun M, Elseviers M, Vander Stichele R, Christiaens T. Durán CE, et al. Among authors: canas m. PLoS One. 2021 Jul 13;16(7):e0254585. doi: 10.1371/journal.pone.0254585. eCollection 2021. PLoS One. 2021. PMID: 34255795 Free PMC article.

9

[Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?].

Marin G, Del Mauro J, Marin L, Urtasun MA, Marin G, Nucher D, Dacher C, Diaz Perez D, Cañás M. Marin G, et al. Among authors: canas m. Salud Colect. 2021 Sep 27;17:e3583. doi: 10.18294/sc.2021.3583. Salud Colect. 2021. PMID: 34752020 Spanish.

10

Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.

Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M. Lopes LC, et al. Among authors: canas m. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404. Epub 2022 Jan 13. Pharmacoepidemiol Drug Saf. 2022. PMID: 34957616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page